Cha‐Xiang Guan
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 11
- Immunology top 5%
- Inflammation biomarkers and pathways 14
-
- Neonatal Respiratory Health Research 19
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 10
- Cancer Research top 10%
-
- Neuropeptides and Animal Physiology 10
-
- Inflammasome and immune disorders 10
-
- Tuberculosis Research and Epidemiology 7
-
- Mycobacterium research and diagnosis 7
Cha‐Xiang Guan
93 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Biochemistry 316
- Immunology 708
- Critical Care and Intensive Care Medicine 119
- Pulmonary and Respiratory Medicine 612
- Cancer Research 246
Countries citing papers authored by Cha‐Xiang Guan
This map shows the geographic impact of Cha‐Xiang Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cha‐Xiang Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cha‐Xiang Guan more than expected).
Fields of papers citing papers by Cha‐Xiang Guan
This network shows the impact of papers produced by Cha‐Xiang Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cha‐Xiang Guan. The network helps show where Cha‐Xiang Guan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cha‐Xiang Guan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 19 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 14 | |
| 11 | 2021 | 30 | |
| 12 | 2020 | 17 | |
| 13 | 2020 | 162 | |
| 14 | 2019 | 36 | |
| 15 | 2016 | 2 | |
| 16 | 2015 | 59 | |
| 17 | 2008 | 7 | |
| 18 | 2007 | 12 | |
| 19 | Effect of vasoactive intestinal peptide on pulmonary surfactants phospholipid synthesis in lung explants. | 2004 | 13 |
| 20 | 2001 | 25 |
About Cha‐Xiang Guan
Cha‐Xiang Guan is a scholar working on Biochemistry, Immunology and Pulmonary and Respiratory Medicine, having authored 96 papers that have together received 2.4k indexed citations. Recurring topics across this work include Neonatal Respiratory Health Research (19 papers), Inflammation biomarkers and pathways (14 papers), Eicosanoids and Hypertension Pharmacology (11 papers), Neuropeptides and Animal Physiology (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Inflammasome and immune disorders (10 papers), Tuberculosis Research and Epidemiology (7 papers) and Mycobacterium research and diagnosis (7 papers). The work is most often cited by research in Biochemistry (316 citations), Immunology (708 citations) and Critical Care and Intensive Care Medicine (119 citations). Cha‐Xiang Guan has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Yong Zhou, Hui‐Hui Yang, Wenjing Zhong, Jia‐Xi Duan, Xinxin Guan, Jian‐Bing Xiong, Chen‐Yu Zhang, Chen‐Chen Sun, Jianxin Jiang and Xiang Fang. Their work appears in journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.